| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | Director | Common Stock | 898,131 | $736,467 | $0.8200 | 28 Feb 2022 | By Spouse |
| Karyopharm Therapeutics Inc. | Director | Common Stock | 713,757 | $585,281 | $0.8200 | 28 Feb 2022 | Direct |
| Verastem, Inc. | President of Development, Director | Common Stock | 8,666 | $86,660 | $10.00 | 21 Nov 2025 | Direct |
| Adicet Bio, Inc. | Director | Common Stock | 5,900 | $8,437 | $1.43 | 05 Jun 2024 | Direct |
| Verastem, Inc. | President of Development, Director | Stock Option (right to buy) | 200,000 | 06 Jan 2026 | Direct | ||
| FIBROGEN INC | Director | Stock Option (Right to Buy) | 120,000 | 04 Jun 2025 | Direct | ||
| Karyopharm Therapeutics Inc. | Director | Stock Option (right to buy) | 27,000 | 28 Feb 2022 | Direct | ||
| Adicet Bio, Inc. | Director | Stock Option (Right to Buy) | 26,400 | 21 Aug 2024 | Direct | ||
| Kezar Life Sciences, Inc. | Director | Stock Option (right to buy) | 5,000 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VSTM | Verastem, Inc. | 06 Jan 2026 | 1 | $0 | 4 | President of Development, Director | 08 Jan 2026, 16:01 |
| VSTM | Verastem, Inc. | 21 Nov 2025 | 1 | -$85,500 | 4 | Director | 25 Nov 2025, 17:34 |
| KZR | Kezar Life Sciences, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 17:00 |
| FGEN | FIBROGEN INC | 04 Jun 2025 | 2 | $0 | 4 | Director | 06 Jun 2025, 16:17 |
| FGEN | FIBROGEN INC | 04 Jun 2025 | 0 | $0 | 3 | Director | 06 Jun 2025, 16:16 |
| VSTM | Verastem, Inc. | 22 May 2025 | 2 | $0 | 4 | Director | 27 May 2025, 17:44 |
| ACET | Adicet Bio, Inc. | 21 Aug 2024 | 6 | $0 | 4 | Director | 23 Aug 2024, 16:05 |
| KZR | Kezar Life Sciences, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:20 |
| VSTM | Verastem, Inc. | 18 Jun 2024 | 2 | $0 | 4 | Director | 20 Jun 2024, 20:30 |
| ACET | Adicet Bio, Inc. | 05 Jun 2024 | 3 | -$8,437 | 4 | Director | 07 Jun 2024, 16:05 |
| VSTM | Verastem, Inc. | 11 Mar 2024 | 9 | $0 | 4 | Director | 13 Mar 2024, 18:07 |
| ACET | Adicet Bio, Inc. | 14 Aug 2023 | 6 | $0 | 4 | Director | 16 Aug 2023, 19:07 |
| KZR | Kezar Life Sciences, Inc. | 24 Jul 2023 | 8 | $0 | 4 | Director | 26 Jul 2023, 17:04 |
| KZR | Kezar Life Sciences, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:36 |
| ACET | Adicet Bio, Inc. | 01 Jun 2023 | 2 | $0 | 4 | Director | 02 Jun 2023, 17:48 |
| VSTM | Verastem, Inc. | 15 May 2023 | 1 | $0 | 4 | Director | 16 May 2023, 16:34 |
| VSTM | Verastem, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:10 |
| KZR | Kezar Life Sciences, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 18:04 |
| ACET | Adicet Bio, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:38 |
| VSTM | Verastem, Inc. | 12 May 2022 | 1 | $0 | 4/A | Director | 20 Dec 2022, 15:07 |
| KPTI | Karyopharm Therapeutics Inc. | 28 Feb 2022 | 4 | -$127,477 | 4 | Director | 02 Mar 2022, 14:18 |
| KPTI | Karyopharm Therapeutics Inc. | 17 Feb 2022 | 2 | -$220,246 | 4 | Director | 22 Feb 2022, 15:14 |
| KPTI | Karyopharm Therapeutics Inc. | 07 Feb 2022 | 2 | -$132,851 | 4 | Director | 09 Feb 2022, 16:24 |
| KZR | Kezar Life Sciences, Inc. | 03 Jan 2022 | 3 | -$52,700 | 4 | Director | 05 Jan 2022, 17:51 |
| ACET | Adicet Bio, Inc. | 17 Nov 2021 | 1 | $0 | 4 | Director | 18 Nov 2021, 06:13 |
| ACET | Adicet Bio, Inc. | 17 Nov 2021 | 0 | $0 | 3 | Director | 18 Nov 2021, 06:09 |
| KZR | Kezar Life Sciences, Inc. | 28 Jun 2021 | 1 | $0 | 4 | Director | 30 Jun 2021, 18:47 |
| VSTM | Verastem, Inc. | 28 Jun 2021 | 1 | $0 | 4 | Director | 30 Jun 2021, 13:56 |